Skip to main content
Have a personal or library account? Click to login
Irritable Bowel Syndrome and the Small Intestinal Microflora. What We Do Know? Cover

Irritable Bowel Syndrome and the Small Intestinal Microflora. What We Do Know?

Romanian Journal of Internal Medicine
Volume 53 (2015): Issue 1 (March 2015)
By: ,   and    
Open Access
|Oct 2015
References

References

  1. 1. ZAMAN A. Irritable bowel syndrome. Clin Cornerstone. 2002; 4:22-33.
    Open DOISearch in Google Scholar
  2. 2. BRANDT LJ, CHEY WD, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 Suppl. 1:S1.
    Open DOISearch in Google Scholar
  3. 3. DROSSMAN DA, LI Z, ANDRUZZI E, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569.
    Open DOISearch in Google Scholar
  4. 4. HAHN BA, SAUNDERS WB, MAIER WC. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997; 42:2585.
    Open DOISearch in Google Scholar
  5. 5. SAITO YA, LOCKE GR, TALLEY NJ, et al. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000; 95:2816.
    Open DOISearch in Google Scholar
  6. 6. TALLEY NJ, ZINSMEISTER AR, VAN DYKE C, MELTON LJ 3rd. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101:927.
    Open DOISearch in Google Scholar
  7. 7. THOMPSON WG, IRVINE EJ, PARE P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002; 47:225.
    Open DOISearch in Google Scholar
  8. 8. HUNGIN AP, WHORWELL PJ, TACK J, MEARIN F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment PharmacolTher 2003; 17:643.
    Open DOISearch in Google Scholar
  9. 9. DROSSMAN DA. Rome III: the new criteria. Chin J Dig Dis. 2006; 7(4):181-5.
    Open DOISearch in Google Scholar
  10. 10. DONALDSON RM, JR. Normal bacterial populations of the intestine and their relation to intestinal function. N Engl J Med. 1964;270:1050-1056.
    Open DOISearch in Google Scholar
  11. 11. FORD AC, SPIEGEL BM, TALLEY NJ, MOAYYEDI P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. ClinGastroenterolHepatol.2009;7:1279-1286.
    Open DOISearch in Google Scholar
  12. 12. BONFRATE L, TACK J, GRATTAGLIANO I, CUOMO R, PORTINCASA P. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol.2013; 48(9):995-1009.
    Open DOISearch in Google Scholar
  13. 13. PYLERIS E, GIAMARELLOS-BOURBOULIS EJ, TZIAVRAS D, KOUSSOULAS V, BARBATZAS C, PIMENTEL M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci.2012; 57(5):1321-9.
    Open DOISearch in Google Scholar
  14. 14. SEKIROV I, RUSSELL SL, CAETANO M ANTUNES L, FINLAY BB. Gut microbiota in health and disease. Physiological Reviews.2010;90(3):859-904.
    Open DOISearch in Google Scholar
  15. 15. PONNUSAMY K, CHOI JN, KIM J, LEE S-Y, LEE CH. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. Journal of Medical Microbiology 2011;60(6):817-827.
    Open DOISearch in Google Scholar
  16. 16. KANG NL, OH YL. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.World J Gastroenterol. Jul 21, 2014; 20(27): 8886-8897.
    Search in Google Scholar
  17. 17. CARRARA M, DESIDERI S, AZZURRO M, et al. Small intestine bacterial overgrowth in patients with irritable bowel syndrome. European Review for Medical and Pharmacological Sciences. 2008; 12(3):197-202.
    Search in Google Scholar
  18. 18. MALINEN E, RINTTILÄ T, KAJANDER K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. American Journal of Gastroenterology, 2005; 100(2):373-38.
    Open DOISearch in Google Scholar
  19. 19. CHOW J, LEE SM, SHEN Y, KHOSRAVI A, MAZMANIAN SK. Host-bacterial symbiosis in health and disease. Advances in Immunology.2010; 107(C):243-274.
    Open DOISearch in Google Scholar
  20. 20. POSSERUD I, STOTZER PO, BJÖRNSSON ES, ABRAHAMSSON H, SIMRÉN M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007; 56(6):802-808.
    Open DOISearch in Google Scholar
  21. 21. TOSKES PP. Bacterial overgrowth of the gastrointestinal tract. Adv Int Med. 1993; 38:387-407.
    Search in Google Scholar
  22. 22. VANNER S. The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment. Gut 2008; 57:1315-1321.
    Open DOISearch in Google Scholar
  23. 23. GHOSHAL UC, SRIVASTAVA D, GHOSHAL U, MISRA A. Breath tests in the diagnosis of small intestinal bacterial over growth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Eur J GastroenterolHepatol. 2014 Jul; 26(7):753-60.
    Open DOISearch in Google Scholar
  24. 24. NEWCOMER AD, MCGILL DB, THOMAS PJ, HOFMANN AF. Prospective comparison of indirect methods for detecting lactase deficiency. N Engl J Med. 1975;293:1232-1236.
    Open DOISearch in Google Scholar
  25. 25. URITA Y, ISHIHARA S, AKIMOTO T, KATO H, HARA N, HONDA Y, NAGAI Y, NAKANISHI K, SHIMADA N, SUGIMOTO M, et al. Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth. World J Gastroenterol.2006; 12:3092-3095.
    Open DOISearch in Google Scholar
  26. 26. PERMAN JA, MODLER S, BARR RG, ROSENTHAL P. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984; 87:1358-1363.
    Open DOISearch in Google Scholar
  27. 27. PIMENTEL M, CHOW EJ, LIN HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503-3506.
    Open DOISearch in Google Scholar
  28. 28. GHOSHAL UC, GHOSHAL U, DAS K, MISRA A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25:6-10.
    Search in Google Scholar
  29. 29. BOND JH, LEVITT MD. Use of breath hydrogen (H2) to quantitate small bowel transit time following partial gastrectomy. J Lab Clin Med. 1977; 90:30-36.
    Search in Google Scholar
  30. 30. KING TS, ELIA M, HUNTER JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet.1998; 352:1187-1189.
    Open DOISearch in Google Scholar
  31. 31. GHOSHAL UC. How to Interpret Hydrogen Breath Tests. Neurogastroenterol Motil. Jul 2011; 17(3): 312-317.
    Open DOISearch in Google Scholar
  32. 32. PIMENTEL M, CHOW EJ, LIN HC. Normalization of lactulose breathtesting correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol.2003; 98:412-419.
    Search in Google Scholar
  33. 33. SCARPELLINI E1, GIORGIO V, GABRIELLI M, FILONI S, VITALE G, TORTORA A, OJETTI V, GIGANTE G, FUNDARÒ C, GASBARRINI A. Rifaximin treatment for small intestinalbacterialovergrowth in children with irritable bowel syndrome. Eur Rev Med Pharmacol Sci. 2013 May; 17(10):1314-20.
    Search in Google Scholar
  34. 34. YAKOOB J, ABBAS Z, KHAN R, HAMID S, AWAN S, JAFRI W. Small intestinal bacterial overgrowth and lactose intolerance contribute to irritable bowel syndrome symptomatology in Pakistan. Saudi J Gastroenterol. 2011; 17:371-375.
    Open DOISearch in Google Scholar
  35. 35. MEYRAT P, SAFRONEEVA E, SCHOEPFER AM. Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months. Aliment PharmacolTher. 2012; 36:1084-1093.
    Open DOISearch in Google Scholar
  36. 36. LUPASCU A, GABRIELLI M, LAURITANO EC, SCARPELLINI E, SANTOLIQUIDO A, CAMMAROTA G, FLORE R, TONDI P, POLA P, GASBARRINI G, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther. 2005; 22:1157-1160.
    Open DOISearch in Google Scholar
  37. 37. REDDYMASU SC, SOSTARICH S, MCCALLUM EW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterol. 2010; 10:23.
    Search in Google Scholar
  38. 38. MORARU IG, MORARU AG, MIHAI A, CIORTESCU I, DRUG V, PORR P, VOIOSU R, IORDACHE T, DICULESCU M, PORTINCASA P, DUMITRASCU DL. Small intestinal bacterial overgrowth is associated to symptoms in irritable bowel syndrome. Evidence from a multicentre study in Romania. Rom J Intern Med. 2014, 52 (4). .
    Search in Google Scholar
  39. 39. HUSEBYE E. The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy.2005; 51(suppl 1):1-22.
    Open DOISearch in Google Scholar
  40. 40. PISTIKI A, GALANI I, PYLERIS E, BARBATZAS C, PIMENTEL M, GIAMARELLOS-BOURBOULIS EJ. In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth. Int J Antimicrob Agents. 2014 Jan 6.pii: S0924-8579(13)00412-3.
    Search in Google Scholar
  41. 41. MAGNUS S, GIOVANNI B, HARRY JF, BRENNAN MRS, ROBIN CS, STEPHEN V. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. Jan 2013; 62(1): 159-176.
    Search in Google Scholar
DOI: https://doi.org/10.1515/rjim-2015-0014 | Journal eISSN: 2501-062X (formerly 1220-4749) | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English, Romanian
Page range: 105 - 109
Submitted on: Jan 12, 2015
Published on: Oct 7, 2015
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Keywords:
Irritable bowel syndrome,
Small Intestinal bacterial overgrowth,
Hydrogen breath tests,
Rifaximin
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2015 Ioana G. Moraru, A.G. Moraru, D.L. Dumitraşcu, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 53 (2015): Issue 1 (March 2015)
Previous article